Rameen Kasana
Wed, December 10, 2025 astatine 9:33 AM CST 2 min read
TD Cowen highlighted that the company’s 2026 EPS volition beryllium wrong a circumstantial range, portion the banal trades astatine a decade-low valuation, implying it is “largely de-risked.” The expert believes the company’s caller rebate-free pharmacy payment absorption (PBM) exemplary volition beryllium the archetypal measurement toward broader PBM reforms that could code regulatory issues and thrust amended valuation. What’s adjacent much absorbing is that the steadfast described the company’s conception guidance arsenic “conservative,” emphasizing halfway net from the specialty pharmacy business.
Pixabay/Public Domain
Separately, connected December 2, Guggenheim maintained its ‘Buy’ standing connected The Cigna Group (NYSE:CI) and raised its terms people to $318 from $309, according to TheFly. This revision reflects an upside imaginable of 20%.
The Cigna Group (NYSE:CI) is simply a Connecticut-based supplier of security and related products and services. Founded successful 1792, the institution chiefly operates done Evernorth Health Services and Cigna Healthcare segments.
While we admit the imaginable of CI arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.

1 day ago
3




English (CA) ·
English (US) ·
Spanish (MX) ·